1Dormuth CR, Hemmelgam BR, Paterson JM, et al. Use of highpotency statins and rates of admission for acute kidney injury :multicenter, retrospective observational analysis of administrativedatabases. BMJ, 2013,346:1880. 被引量：1
2Wu Y, Wang Y,An C,et al. Effects of rosuvastatin andatorvastatin on renal function: meta-analysis. Circ J, 2012 ,76 :1259-1266. 被引量：1
3Prospective evaluation of proteinuria and renal function in diabeticpatients with progressive renal disease ( PLANET I) : [ DB/OL].[2013-05-28 ]. http://clinicaltrials. gov/ct2/show/NCT0Q296374?term - PLANET + 1 &rank = 1. 被引量：1
4Cholesterol Treatment Trialists, ( CTT) Collaboration, Baigent C,Blackwell L, et al. Efficacy and safety of more intensive loweringof LDL cholesterol : a meta-analysis of data from 170,000participants in 26 randomised trials. Lancet, 2010, 376 : 1670-1681. 被引量：1
5Cholesterol Treatment Trialists, ( CTT) Collaborators, MihaylovaB,Emberson J, et al. The effects of lowering LDL cholesterol withstatin therapy in people at low risk of vascular disease : meta-analysis of individual data from 27 randomised trials. Lancet,2012,380:581-590. 被引量：1
2Guo C,Zhang C, Li L,et al. Hypoglycemic and hypolipi-demic effects of oxymatrine in high-fat diet and streptozo-tocin-induceddiabetic rats [J]. Phytomedicine. 2014, 21(6):807-814. 被引量：1
3Awoniyi O, Gosmanov AR. Myopathy after switchingfrom brand to genericatorvastatin[J]. Am Geriatr Soc,2013,61(12) :2254-2255. 被引量：1
